To confirm the protective role of TGF-β1 in microvascular inflammation, we treated SCD mice with a monoclonal antibody able to neutralize the TGF-β isoforms 1, 2, and 3. This evidence concerns the gene TGFB1 and Schnyder corneal dystrophy.